Friday, 20 Sep 2019

You are here

CKD is a gout risk factor

Impaired renal function is a known primary contributor to hyperuricemia and risk of gout. Investigators from Stanford University sought to use the Framingham Database to identify if chronic kidney disease (CKD) is an independent risk factor for gout. Among 4700+ patients and 52 years of followup, they found 371 self identified incident gout cases. After adjustments for age, sex, BMI, alcohol use, smoking, hypertension, diabetes and menopause, CKD was associated with an HR of 2.09 (95% CI 1.41 to 3.08) for gout overall, this study confirms the association between CKD and gout. [Image: "The Gout by James Gillray. Published May 14th 1799. Via copy at [1]. Licensed under Public Domain via Wikimedia Commons."]

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Higher Rates of Venous Thromboembolism in Gout

A Canadian administrative claims analysis has shown that gout-associated inflammation increases the risk of venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE) before and after the diagnosis of gout.

Modifiable Risk Factors for Hyperuricemia

Choi and colleagues have shown that four modifiable risk factors (BMI, the DASH diet, alcohol use, and diuretic use) could individually account for a notable proportion of observed hyperuricemia. 

Researchers examine modifiable risk factors for hyperuricemia and how this could be prevented through risk factor modification in the general population.

Opioids Overused in Acute Gout

Opioids were commonly given to patients as a treatment for acute gout attacks, despite the availability of other effective and appropriate therapies, a retrospective study found.

Allopurinol Fails to Curtail Hypertension

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. A novel trial presented at EULAR 2019 last week assessed whether the use of urate-lowering therapy (ULT) would control hypertension in those at risk; however, results of this trial were largely negative.

Hypertension is one of the many comorbidities that plagues gout patients.

Allopurinol Fails to Curtail Hypertension

A novel trial presented at EULAR 2019 last week assessed whether the use of urate-lowering therapy (ULT) would control hypertension in those at risk; however, results of this trial were largely negative.

Hypertension is one of the many comorbidities that plagues gout patients.